Equities analysts predict that Evolent Health Inc (NYSE:EVH) will report earnings of ($0.04) per share for the current quarter, according to Zacks. Nine analysts have issued estimates for Evolent Health’s earnings, with the highest EPS estimate coming in at ($0.02) and the lowest estimate coming in at ($0.07). Evolent Health reported earnings per share of ($0.18) during the same quarter last year, which would suggest a positive year-over-year growth rate of 77.8%. The company is scheduled to report its next earnings results after the market closes on Tuesday, February 27th.
According to Zacks, analysts expect that Evolent Health will report full year earnings of ($0.36) per share for the current financial year, with EPS estimates ranging from ($0.40) to ($0.32). For the next year, analysts expect that the company will post earnings of ($0.05) per share, with EPS estimates ranging from ($0.07) to ($0.03). Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Evolent Health.
EVH has been the topic of several research analyst reports. Leerink Swann set a $25.00 target price on shares of Evolent Health and gave the stock a “buy” rating in a report on Saturday, November 18th. Cantor Fitzgerald reissued a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a report on Thursday, November 2nd. SunTrust Banks reissued a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a report on Friday, November 3rd. Citigroup initiated coverage on shares of Evolent Health in a report on Thursday, January 4th. They issued a “buy” rating on the stock. Finally, Goldman Sachs Group downgraded shares of Evolent Health from a “conviction-buy” rating to a “buy” rating in a report on Tuesday, November 7th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have assigned a buy rating to the company. Evolent Health has a consensus rating of “Buy” and an average target price of $27.40.
Evolent Health (NYSE:EVH) opened at $14.15 on Friday. Evolent Health has a 1-year low of $10.30 and a 1-year high of $27.50. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.34 and a quick ratio of 3.34. The company has a market cap of $1,102.04, a price-to-earnings ratio of -12.61 and a beta of 1.24.
Evolent Health Company Profile
Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.